Z
Zaoqu Liu
Researcher at Zhengzhou University
Publications - 95
Citations - 892
Zaoqu Liu is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 6, co-authored 26 publications receiving 78 citations.
Papers
More filters
Journal ArticleDOI
Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer.
Zaoqu Liu,Taoyuan Lu,Yanli Wang,Dechao Jiao,Zhaonan Li,Libo Wang,Long Liu,Chunguang Guo,Yanan Zhao,Xinwei Han +9 more
TL;DR: Wang et al. as mentioned in this paper proposed an integrated algorithm, ImmuMiRNA, for identifying miRNA modulators of immune-associated pathways, and applied the LASSO algorithm to develop a reliable and individualized signature for evaluating overall survival (OS) and inflammatory landscape of colorectal cancer patients.
Journal ArticleDOI
Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma.
Zaoqu Liu,Long Liu,Dechao Jiao,Chunguang Guo,Libo Wang,Zhaonan Li,Zhenqiang Sun,Yanan Zhao,Xinwei Han +8 more
TL;DR: A novel gene whose mutation could be served as a potential biomarker for prognosis, TMB, and immunotherapy of EAC patients is revealed.
Journal ArticleDOI
Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.
TL;DR: Wang et al. as mentioned in this paper used consensus clustering algorithm and public datasets to identify heterogeneous hypoxia subtypes in hepatocellular carcinoma (HCC) and revealed the specific biological and clinical characteristics via bioinformatic methods.
Journal ArticleDOI
Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma.
TL;DR: The findings suggested the TSG subtypes could serve as a promising biomarker for guiding surveillance protocol and immunotherapeutic decisions for patients with HCC.
Journal ArticleDOI
Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma.
Zaoqu Liu,Siyuan Weng,Hui Xu,Libo Wang,Long Liu,Yuyuan Zhang,Chunguang Guo,Qin Dang,Zhe Xing,Taoyuan Lu,Xinwei Han +10 more
TL;DR: Wang et al. as mentioned in this paper proposed an integrated framework that enables the identification of TGF-β-derived miRNAs in intrahepatic cholangiocarcinoma (ICC).